ADCT
Price:
$1.05
Market Cap:
$133.55M
ADC Therapeutics S.A. operates as a commercial-stage biotechnology company, focused on developing antibody-drug conjugates (ADCs) for the treatment of hematological malignancies and solid tumors. Its flagship product, ZYNLONTA, is presently being evaluated in multiple clinical trials: a Phase II study for relapsed or refractory diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma; a Phase III trial assessing its combination with rituximab for second-line, transplant-ineligible patients with relapsed or refractory DLBCL; and a Phase I trial for relapsed or refractory non-Hodgkin lymphoma (NHL). The company's pipeline also includes camidanlumab tesirine, another ADC, which has complet...[Read more]
Industry
Biotechnology
IPO Date
2020-05-18
Stock Exchange
NYSE
Ticker
ADCT
According to ADC Therapeutics S.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 323.90M. This represents a change of -37.19% compared to the average of 515.68M of the last 4 quarters.
The mean historical Enterprise Value of ADC Therapeutics S.A. over the last ten years is 843.79M. The current 323.90M Enterprise Value has changed 3.74% with respect to the historical average. Over the past ten years (40 quarters), ADCT's Enterprise Value was at its highest in in the June 2020 quarter at 2.63B. The Enterprise Value was at its lowest in in the September 2023 quarter at -113093608.24.
Average
843.79M
Median
924.84M
Minimum
-143669000.00
Maximum
1.87B
Discovering the peaks and valleys of ADC Therapeutics S.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 856.36%
Maximum Annual Enterprise Value = 1.87B
Minimum Annual Increase = -1131.72%
Minimum Annual Enterprise Value = -143669000.00
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 626.22M | 856.36% |
| 2024 | 65.48M | -452.44% |
| 2023 | -18578804.44 | -117.95% |
| 2022 | 103.52M | -91.54% |
| 2021 | 1.22B | -30.86% |
| 2020 | 1.77B | -5.48% |
| 2019 | 1.87B | 28.48% |
| 2018 | 1.46B | -1.69% |
| 2017 | 1.48B | -1131.72% |
The current Enterprise Value of ADC Therapeutics S.A. (ADCT) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
224.37M
5-year avg
400.02M
10-year avg
843.79M
ADC Therapeutics S.A.’s Enterprise Value is less than Omeros Corporation (940.92M), greater than Neumora Therapeutics, Inc. Common Stock (183.14M), less than RAPT Therapeutics, Inc. (923.92M), less than Autolus Therapeutics plc (364.21M), less than Alumis Inc. Common Stock (2.95B), greater than Bicycle Therapeutics plc (-264552133.00), less than Lexicon Pharmaceuticals, Inc. (872.47M), less than 4D Molecular Therapeutics, Inc. (409.65M), greater than Lineage Cell Therapeutics, Inc. (283.06M), greater than Quantum-Si incorporated (154.79M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 940.92M | $632.20M | |
| 183.14M | $329.81M | |
| 923.92M | $959.26M | |
| 364.21M | $415.18M | |
| 2.95B | $2.98B | |
| -264552133.00 | $281.05M | |
| 872.47M | $852.86M | |
| 409.65M | $461.60M | |
| 283.06M | $316.61M | |
| 154.79M | $187.28M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ADC Therapeutics S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like ADC Therapeutics S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is ADC Therapeutics S.A.'s Enterprise Value?
What is the highest Enterprise Value for ADC Therapeutics S.A. (ADCT)?
What is the 3-year average Enterprise Value for ADC Therapeutics S.A. (ADCT)?
What is the 5-year average Enterprise Value for ADC Therapeutics S.A. (ADCT)?
How does the current Enterprise Value for ADC Therapeutics S.A. (ADCT) compare to its historical average?